Dr. Irina Staatz-Granzer, Founder and President of Staatz Business Development & Strategy, describes her biotech and pharma consulting company as having two main areas of expertise, business development and market access. Since its founding in 2006, the company has facilitated deals totaling over $3 billion. They work with clients in Europe, the US, Japan and elsewhere, with a team of highly skill professionals who themselves have worked in the biotech and pharmaceutical fields. Their consulting covers strategic-analytical, scientific and commercial areas as well as pricing and reimbursement.
Staatz Business Development & Strategy offers high-level consulting
Get articles like this by email
Keep up to date with thought-leadership, interviews, surveys and more from our global network of industry experts